<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00335088</url>
  </required_header>
  <id_info>
    <org_study_id>4780506</org_study_id>
    <nct_id>NCT00335088</nct_id>
  </id_info>
  <brief_title>Local Moxifloxacin and Povidone Iodine Versus Povidone Iodine Alone as a Prophylaxis Before Eye Operations</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis is that povidone iodine alone is sufficient for sterilization of the lacrimal
      sac and eye lids before intraocular surgeries. Patients admitted for various intraocular
      surgeries will be randomly allocated to prophylactic local therapy with either moxifloxacin
      and povidone iodine or povidone iodine alone before surgery. Lacrimal sac and eye lid
      cultures will be obtained before the local therapy and just before surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Over all 500 patients admitted for various intraocular surgeries will be included in the
      study. The study will be prospective, double blind, placebo controlled, and randomized.
      Patients will be randomly allocated to prophylactic local therapy with either moxifloxacin
      and povidone iodine or povidone iodine alone before surgery. For patients treated with
      povidone iodine alone a placebo will also be given. Lacrimal sac and eye lid cultures will be
      obtained before the local therapy and just before surgery. All patients will be followed for
      6 weeks for symptoms and signs of infection. Bacterial and fungal culture results will be
      compared between the 2 groups.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2006</start_date>
  <completion_date type="Anticipated">May 2007</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Type and amount of bacterial growth</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Post surgery infections</measure>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Eye Infections</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Moxifloxacin and Povidone Iodine vs Povidone Iodine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 20 years.

          -  Various intraocular surgeries

        Exclusion Criteria:

          -  Need for emergency therapy, immunosuppression, any malignancy, psychomotor
             retardation, drug and alcohol abuse.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Miron, MD</last_name>
    <role>Study Director</role>
    <affiliation>HaEmek Medicak Center, Afula, Israel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Orky Halachmi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>HaEmek Medical Center, Afula, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Orly Halachmi, MD</last_name>
    <phone>972-4-649344</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dan Miron, MD</last_name>
    <phone>972-4-6404316</phone>
    <email>miron_da@yahoo.om</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ophthalmology Department, HaEmek Medical Center, Afula, Israel</name>
      <address>
        <city>Afula</city>
        <zip>18101</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orly Halachmi, MD</last_name>
      <phone>972-4-6494344</phone>
    </contact>
    <contact_backup>
      <last_name>Dan Miron, MD</last_name>
      <phone>972-4-6494316</phone>
      <email>miron_da@yahoo.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yoram Kenes, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2006</study_first_submitted>
  <study_first_submitted_qc>June 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 8, 2006</study_first_posted>
  <last_update_submitted>May 31, 2007</last_update_submitted>
  <last_update_submitted_qc>May 31, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2007</last_update_posted>
  <keyword>Prophylaxis,</keyword>
  <keyword>Intraocular surgery</keyword>
  <keyword>Lacrimal sac</keyword>
  <keyword>Eye lid</keyword>
  <keyword>No conditions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Moxifloxacin</mesh_term>
    <mesh_term>Iodine</mesh_term>
    <mesh_term>Povidone-Iodine</mesh_term>
    <mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
    <mesh_term>Povidone</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>May 11, 2009</submitted>
    <returned>June 25, 2009</returned>
    <submitted>July 22, 2009</submitted>
    <returned>August 27, 2009</returned>
    <submitted>September 4, 2016</submitted>
    <returned>October 25, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

